Nicholas Conrad Smith's most recent trade in Alto Neuroscience Inc. was a trade of 202,329 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 202,329 | 202,329 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 202,329 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 135,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 90,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 44,962 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 44,962 | 44,962 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 33,833 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 33,833 | 33,833 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.56 per share. | 28 Mar 2024 | 4,550 | 26,866 | - | 16.6 | 75,348 | Common Stock |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 15.80 per share. | 28 Mar 2024 | 1,600 | 22,316 | - | 15.8 | 25,280 | Common Stock |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,000 | 90,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 19,153 | 20,716 | - | 0 | Common Stock | |
| Alto Neuroscience Inc. | Nicholas Conrad Smith | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 1,563 | 1,563 | - | 16 | 25,008 | Common Stock |